AU2001267526A1 - Ligands of integrin receptors - Google Patents
Ligands of integrin receptorsInfo
- Publication number
- AU2001267526A1 AU2001267526A1 AU2001267526A AU6752601A AU2001267526A1 AU 2001267526 A1 AU2001267526 A1 AU 2001267526A1 AU 2001267526 A AU2001267526 A AU 2001267526A AU 6752601 A AU6752601 A AU 6752601A AU 2001267526 A1 AU2001267526 A1 AU 2001267526A1
- Authority
- AU
- Australia
- Prior art keywords
- ligands
- integrin receptors
- integrin
- receptors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10027514A DE10027514A1 (de) | 2000-06-06 | 2000-06-06 | Liganden von Integrinrezeptoren |
DE10027514.1 | 2000-06-06 | ||
PCT/EP2001/006397 WO2001093840A2 (de) | 2000-06-06 | 2001-06-06 | Liganden von integrinrezeptoren |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001267526A1 true AU2001267526A1 (en) | 2001-12-17 |
Family
ID=7644555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001267526A Abandoned AU2001267526A1 (en) | 2000-06-06 | 2001-06-06 | Ligands of integrin receptors |
Country Status (10)
Country | Link |
---|---|
US (1) | US20080221082A1 (de) |
EP (1) | EP1286673B8 (de) |
JP (1) | JP2004501120A (de) |
AR (1) | AR028682A1 (de) |
AT (1) | ATE296102T1 (de) |
AU (1) | AU2001267526A1 (de) |
CA (1) | CA2411549A1 (de) |
DE (2) | DE10027514A1 (de) |
MX (1) | MXPA02012015A (de) |
WO (1) | WO2001093840A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006035967A1 (en) * | 2004-09-30 | 2006-04-06 | Taisho Pharmaceutical Co., Ltd. | Pyridine derivatives and their use as medicaments for treating diseases related to mch receptor |
CA2650683A1 (en) * | 2006-04-28 | 2007-11-08 | Shionogi & Co., Ltd. | Amine derivative having npy y5 receptor antagonist activity |
CN101479238B (zh) * | 2006-04-28 | 2013-08-21 | 盐野义制药株式会社 | 具有npyy5受体拮抗活性的胺衍生物 |
SA08290668B1 (ar) * | 2007-10-25 | 2012-02-12 | شيونوجي آند كو.، ليمتد | مشتقات أمين لها نشاط مضاد لمستقبل npy y5 واستخداماتها |
US8227618B2 (en) * | 2009-04-23 | 2012-07-24 | Shionogi & Co., Ltd. | Amine-derivatives having NPY Y5 receptor antagonistic activity and the uses thereof |
PL2604595T3 (pl) * | 2010-08-10 | 2016-09-30 | Pochodna triazyny i związek farmaceutyczny, który ją zawiera i wykazuje aktywność przeciwbólową | |
EP4249471A3 (de) | 2013-09-24 | 2023-10-18 | FUJIFILM Corporation | Pharmazeutische zusammensetzung von stickstoffhaltige verbindung oder salz davon oder metallkomplex davon |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5606054A (en) * | 1993-12-14 | 1997-02-25 | Merck & Co., Inc. | Heterocyclic-fused lactams promote release of growth hormone |
WO1996026190A1 (en) * | 1995-02-22 | 1996-08-29 | Smithkline Beecham Corporation | Integrin receptor antagonists |
UA60311C2 (uk) * | 1996-10-02 | 2003-10-15 | Смітклайн Бічам Корпорейшн | Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція |
US6239138B1 (en) * | 1997-07-25 | 2001-05-29 | Smithkline Beecham Corporation | Vitronectin receptor antagonist |
AU8689798A (en) * | 1997-08-04 | 1999-02-22 | Smithkline Beecham Corporation | Integrin receptor antagonists |
-
2000
- 2000-06-06 DE DE10027514A patent/DE10027514A1/de not_active Withdrawn
-
2001
- 2001-06-05 AR ARP010102685A patent/AR028682A1/es not_active Application Discontinuation
- 2001-06-06 AU AU2001267526A patent/AU2001267526A1/en not_active Abandoned
- 2001-06-06 JP JP2002501413A patent/JP2004501120A/ja active Pending
- 2001-06-06 US US10/297,202 patent/US20080221082A1/en not_active Abandoned
- 2001-06-06 WO PCT/EP2001/006397 patent/WO2001093840A2/de active Application Filing
- 2001-06-06 MX MXPA02012015A patent/MXPA02012015A/es unknown
- 2001-06-06 EP EP01945258A patent/EP1286673B8/de not_active Expired - Lifetime
- 2001-06-06 AT AT01945258T patent/ATE296102T1/de not_active IP Right Cessation
- 2001-06-06 DE DE50106325T patent/DE50106325D1/de not_active Expired - Lifetime
- 2001-06-06 CA CA002411549A patent/CA2411549A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE50106325D1 (de) | 2005-06-30 |
CA2411549A1 (en) | 2002-12-05 |
MXPA02012015A (es) | 2003-06-09 |
EP1286673B8 (de) | 2005-07-20 |
WO2001093840A2 (de) | 2001-12-13 |
ATE296102T1 (de) | 2005-06-15 |
US20080221082A1 (en) | 2008-09-11 |
EP1286673A2 (de) | 2003-03-05 |
AR028682A1 (es) | 2003-05-21 |
EP1286673B1 (de) | 2005-05-25 |
WO2001093840A3 (de) | 2002-08-08 |
JP2004501120A (ja) | 2004-01-15 |
DE10027514A1 (de) | 2002-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL350095A1 (en) | Ligands of melanocortinic receptors | |
AU3213799A (en) | Integrin antagonists | |
AUPQ998100A0 (en) | Application development | |
AU2001288040A1 (en) | Homeostasis-maintaining agents | |
AU2002214284A1 (en) | Anti-helicobacterial agents | |
AU2001234741A1 (en) | Integrin antagonists | |
AU2001279143A1 (en) | Metlblown web | |
AU2001239773A1 (en) | Baroplastic materials | |
AU2001272974A1 (en) | Human receptors | |
AU2001285748A1 (en) | Integrin ligands | |
AU2541000A (en) | Beta-phenylalanine derivatives as integrin antagonists | |
AU2001246934A1 (en) | Agonist antibodies | |
GB0121821D0 (en) | Deposition of soluble materials | |
AU2001296709A1 (en) | Gemstone | |
AU2001286061A1 (en) | Applicator | |
EP1286673B8 (de) | Liganden von integrinrezeptoren | |
GB0011817D0 (en) | Antagonists of integrin receptors | |
AU2001294189A1 (en) | Masking material | |
AU2001294776A1 (en) | Lactone integrin antagonists | |
AU2001274426A1 (en) | Web windowed graphical user interface | |
AU2001240150A1 (en) | Quinazoline synthesis | |
AU2001283669A1 (en) | Backpack | |
AU6614000A (en) | Chimeric receptors and their uses | |
AU6286101A (en) | New use | |
AU2001274683A1 (en) | Contrast agents |